Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed)
Key Information
Due Date: January 7, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant, Government
Match Required: No
Contact Info:
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
Applications for this grant should center on investigating how interactions between the host and specific microbes (or groups of microbes), or their metabolites, affect immune responses. These responses should either enhance or prevent the formation of tumors, whether associated with inflammation or sporadic in nature.
Proposed studies should also closely examine how the effectiveness of beneficial microbes can be influenced by the concentration, timing, and duration of administration. Applicants should rigorously address these parameters in their applications to ensure optimum results. Researchers are encouraged to apply if they are interested in exploring these interactions and impacts, with a focus on achieving potential breakthroughs in cancer prevention.
Key Dates
Open Date: November 3, 2021
Application Due Date: January 7, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses